Clinical Trials Logo

Filter by:
NCT ID: NCT04957953 Completed - Clinical trials for Pregnant Women Vaccinated Against Covid-19

Pregnant Women Vaccinated Against Covid-19.

COVACPREG
Start date: December 2, 2021
Phase:
Study type: Observational

Establish a cohort of pregnant women exposed to a COVID19 vaccine, whether or not they have experienced an adverse event, to assess the potential effects of vaccines on the course of pregnancy, on the fetus or newborn and on the mother.

NCT ID: NCT04957186 Completed - Breast Cancer Clinical Trials

Personalized Follow-up After Breast Cancer Surgery Via Electronic Patient Reported Outcomes

BEAUTIFY-2
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Based on one focus group of caregivers and one group of patients treated by surgery for breast cancer this study is an attempt to identify the specific needs of this population and then develop the BEAUTIFY care pathway.This study aims to build a new multidisciplinary care pathway (BEAUTIFY = BrEast cAncer qUaliTy of lIfe aFter surgerY) with post-operative follow-up via electronic patient-reported outcomes of breast cancer surgery complications in order to optimize the quality of life of patients.

NCT ID: NCT04956783 Completed - Cancer Clinical Trials

Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen

ICI DODO
Start date: June 1, 2021
Phase:
Study type: Observational

This is a retrospective evaluation of the impact of a double dose regimen of immunotherapy use in cancer treatment compared to the single-dose regimen on the occurrence of clinically significant adverse events. The aim of this study is to provide evidence-based arguments to help clinicians to propose the best treatment regimen for each patient.

NCT ID: NCT04954976 Completed - Clinical trials for Orthodontic Retention Procedures

Orthodontic Retention In France - ORIF

ORIF
Start date: January 18, 2021
Phase:
Study type: Observational

The goal of this study is to survey retention procedures used by French orthodontists, and evaluate the needs for practice guidelines. The hypothesis is that there is no consensus among orthodontists, requiring practice homogenization via expert guidelines. Similar studies have been driven in others European countries (such as Swiss, the Netherlands, Lithuania and Norway), but not in France.

NCT ID: NCT04953403 Completed - Alcoholism Clinical Trials

Evaluation of Physical Activity of Patients Admitted to Addiction Service

ACTP-ADDICT
Start date: January 1, 2020
Phase:
Study type: Observational

Addiction is a public health issue that affects nearly 30% of French people according to INSEE. For several years now, the investigators have known that sport is a real help in the fight against addictions, with recent medical authorization to prescribe physical activities. A study from August 2016 claims that regular physical activity may offset the harmful effects of alcohol. (1) Based on the answers given by 36,370 Britons between 1994 and 2006, the researchers showed the existence of a link between the practice of 150 minutes of physical activity per week and the decrease in deaths linked to consumption. alcohol. These results, compared to 18 other studies (2), reveal the benefits of physical activity in the management of addictions. But what about current practice and addictions and sports practice in general ?

NCT ID: NCT04953286 Completed - Clinical trials for Amyotrophic Lateral Sclerosis

Ocular Surface Metabolo-lipidomics in Lateral Amyotrophic Sclerosis

LARMOMIQUE
Start date: September 17, 2021
Phase: N/A
Study type: Interventional

Amyotrophic Lateral Sclerosis (ALS) is the most common neurodegenerative disease affecting the motor neuron. Currently, there is no diagnostic test and no examination that can predict the evolution of this pathology. The search for diagnostic and prognostic biomarkers is therefore essential for a better understanding of the pathophysiology of ALS, which remains poorly understood, and also for better clinical management. The ocular surface, made up of liquid elements, tears, and cells, is an accessible anatomical-physiological entity that has demonstrated its usefulness in the identification of biomarkers in neurodegenerative diseases such as Parkinson's or Alzheimer's. To date, no study has explored the ocular surface as a biomarker in ALS

NCT ID: NCT04952909 Completed - Clinical trials for Risk of Coronary Obstruction Following TAVR Procedure

The ShortCutâ„¢ Study Protocol

Start date: January 21, 2022
Phase: N/A
Study type: Interventional

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCutâ„¢ device for splitting bioprosthetic aortic valve leaflets in patients who are presented for a valve-in-valve transcatheter aortic valve replacement (TAVR) procedure for an approved ViV indication, and who are at risk for TAVR-induced coronary artery ostium obstruction.

NCT ID: NCT04952766 Completed - Cancer Clinical Trials

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

EREVA
Start date: March 26, 2021
Phase: Phase 4
Study type: Interventional

The primary endpoint of this study is to compare the humoral response (titre and neutralizing capacity of induced antibodies) against SARS-CoV-2 following vaccination with BNT162b2 (Pfizer BioNTech) in immunocompromised persons, in comparison to healthy subject. Secondary objectives are to evaluate the humoral response in the nasal mucosa, and the capacity of antibodies to neutralize emerging variants of concerns and to prevent COVID-19.

NCT ID: NCT04950244 Completed - Chest Pain Clinical Trials

Diagnostic Evaluation of Out-of-hospital High-sensitivity Troponin I in Patients Presenting Chest Pain

VALIDATE
Start date: August 20, 2021
Phase:
Study type: Observational

Conducting an analysis of the clinical performance of high-sensitivity cardiac troponin I, tested in the out-of-hospital setting, for ruling out cardiac origin in acute onset chest pain. Acute onset chest pain is a complex symptom to narrow down in the out-of-hospital setting. This is due to the difficulty of obtaining pertinent information over the phone, and the absence of validated dispatch scores or criteria. In France, the current standard of care relies on the rapid dispatch of Emergency Medical Response Teams along with a physician in patients presenting symptoms evocative of Coronary Artery Disease or Myocardial Infarction. Typical anginal pain includes retrosternal pressure pain radiating to the jaw, neck, or left arm. Diagnostic work-up includes anamnesis, physical examination, routine blood work, and ECG. In the absence of signification ST-segment modifications, the gold standard relies on trending serum Troponin T and I in the hospital setting . This study aims to analyze the clinical performance of high-sensitivity cardiac Troponin I assays (hs-cTnI) in the out-of-hospital setting using a point-of-care device ; Atellica VTLi (Siemens Healthineers)

NCT ID: NCT04949893 Completed - Chronic Pruritus Clinical Trials

Causes of Chronic Pruritus

PRURISINE
Start date: May 2, 2019
Phase:
Study type: Observational

The aim of this study is to include all patients followed between 2008 and 2018 in order to analyze the etiologie of the chronic pruritus